You may have seen this5 Mar 2020 13:05
But it is very encouraging, taken from the 27th of February regarding the new FD but confirms they are on the c19 case -
Cathal Friel, Executive Chairman of Open Orphan commented:
"We are delighted to welcome Leo Toole to the board following the successful completion of his regulatory due diligence checks. Leo brings with him a wealth of experience which will be invaluable to us at what is an exciting time for Open Orphan as we steer the company to profitability in the coming months and increasing deal flow and revenue in the year ahead, he is a great addition to the board. These are exciting times for Open Orphan because following the acquisition of hVIVO we are now the world leader in the provision of viral challenge study models and, as such, we are ideally positioned to provide assistance and help to vaccine manufacturers and governments around the world to successfully deal with and in the search for solutions to the Coronavirus outbreak."